s6y

ONCOLYTICS BIOTECH INC

Ticker
ONCY
CIK
1129928
Industry
Pharmaceutical Preparations

Financials 4

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025

News 32

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 32 news filings

Ownership 58

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 58 ownership filings

Prospectus 11

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-3 Registration statement for specified transactions by certain issuers
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 11 prospectus filings

Proxies 2

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements

Other 1,153

  1. F-10POS Post-effective amendment to a F-10EF registration
  2. F-10POS Post-effective amendment to a F-10EF registration
  3. F-10POS Post-effective amendment to a F-10EF registration
  4. F-10POS Post-effective amendment to a F-10EF registration
  5. F-10POS Post-effective amendment to a F-10EF registration
  6. F-10POS Post-effective amendment to a F-10EF registration
  7. F-10POS Post-effective amendment to a F-10EF registration
  8. F-10POS Post-effective amendment to a F-10EF registration
  9. F-10POS Post-effective amendment to a F-10EF registration
  10. F-10POS Post-effective amendment to a F-10EF registration

All 1,153 other filings